ascopubs.org

Rictor amplification to define a novel and unique subset of lung cancer patients.

Clinical activity of LY2835219, a novel cell cycle inhibitor selective for CDK4 and CDK6, in patients with non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual ...
ascopubs.org

KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal ...

Correlation between mismatch repair deficiency (MMRd), microsatellite instability (MSI) and survival in MAGIC. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does ...